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Abstract Skeletal muscle nebulin is thought to determine thin
¢lament length and regulate actomyosin interaction in a calci-
um/calmodulin or S100 sensitive manner. We have investigated
the binding of nebulin SH3 with proline-rich peptides derived
from the 28-mer PEVK modules of titin and the Z-line protein
myopalladin, using £uorescence, circular dichroism and nuclear
magnetic resonance techniques. Of the six peptides studied, PR2
of titin (VPEKKAPVAPPK) and myopalladin MyoP2
(646VKEPPPVLAKPK657) bind to nebulin SH3 with micromo-
lar a⁄nity (V31 and 3.4 WM, respectively), whereas the other
four peptides bind weakly (s 100 WM). Sequence analysis of
titins reveals numerous SH3 binding motifs that are highly en-
riched in the PEVK segments of titin isoforms. Our ¢ndings
suggest that titin PEVK and myopalladin may play signaling
roles in targeting and orientating nebulin to the Z-line during
sarcomere assembly.
8 2002 Published by Elsevier Science B.V. on behalf of the
Federation of European Biochemical Societies.
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1. Introduction
The Src homology-3 (SH3) domain, a family of small glob-
ular domains of 60 amino acids, serves as a mediator of pro-
tein^protein interactions in signaling pathways [1]. It has a
hydrophobic cleft formed by two orthogonal L-sheets that
binds polyproline type II helices with a core binding motif
PxxP [2]. Structural studies of SH3 domain^ligand complexes
have led to a general model for SH3^ligand interactions and
identi¢ed two classes of SH3 ligands that bind SH3 domains
in opposite orientations: class I, with the consensus sequence
RxxPxxP, and class II, with the consensus sequence xPxxPxR
[3].
Nebulin, which consists of an acidic N-terminal domain, 35
residue module repeats, a linker domain and a C-terminal
SH3 domain, is thought to determine thin ¢lament length of
skeletal muscle and regulate actomyosin interaction in a cal-
cium/calmodulin or S100 sensitive manner [4^7]. The C-termi-
nal SH3 domain of nebulin (nSH3) is anchored at the Z-line
and thus orients and aligns the V1 Wm long molecule along
the length of the thin ¢laments [8^11]. The presence of a SH3
domain at the C-terminus of nebulin (700^800 kDa) as well as
the heart speci¢c analog nebulette (107 kDa) and in the re-
cently discovered giant protein obscurin (721 kDa) [12,13] in
striated muscle sarcomeres has led to the search for SH3 re-
ceptors in the sarcomere. Since nuclear magnetic resonance
(NMR) investigations have indicated that the nebulin SH3
domain folds as a typical all-L SH3 fold [14], one expects
proteins with polyproline II helices to be prime targets. Poli-
tou et al. [14] speculated that the sequence, TPPRIPPKKP, of
human cardiac titin Z domains is a likely candidate. We have
observed that cloned human fetal nSH3 binds actin, tropo-
myosin and troponin in solid-state assays [7]. Recently, my-
opalladin (145 kDa) has been identi¢ed as a receptor that
simultaneously links nebulin SH3 and K-actinin in the
Z-line. One PPP-containing peptide of myopalladin was iden-
ti¢ed as a binding site by yeast two-hybrid screening of muta-
genized constructs [15].
Titin is a family of giant elastic proteins (3^4 MDa) that
consists of serially linked motifs of three types: the folded 100
residue modular repeats of immunoglobin or ¢bronectin do-
mains, a unique PEVK motif and the N2-A or N2-B insert
[16]. The notion that the PEVK region of titin may contain
numerous SH3 recognition sites was prompted by our search
for six common SH3 binding motifs in titin isoforms that
revealed a surprisingly large number of these motifs, with
class I and II being the most abundant and enriched in the
PEVK regions.
Experimentally, we have demonstrated by circular dichro-
ism (CD), £uorescence spectroscopy and NMR techniques the
binding of the nSH3 to proline-rich peptides of myopalladin
and the PEVK segment of titin that conform to the canonical
consensus sequences for SH3 binding peptides. We report that
myopalladin MyoP2, with a PPP motif, and PR2, which con-
forms to both the class I and class II motifs, bind to nSH3
with micromolar a⁄nity (V31 and 3.4 WM, respectively),
whereas the other four peptides bind weakly (s 100 WM).
These observations pose an intriguing functional implication
of titin PEVK segments and Z-line SH3 binding proteins such
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as myopalladin for the nebulin targeting pathway during the
IZI assembly.
2. Materials and methods
2.1. Search for SH3 binding motifs
The search for SH3 binding motifs on myopalladin and titin/PEVK
isoforms was performed using Protein Subsequence within MacVector
(version 98) for: PxxP [2], KxxPxxP [3], xPxxPxK [3], xPxxxxPV(A)xP
[2], PxxxKxxKP [17] and PxxDY [18].
Myopalladin (EMBL, AF328296, residues 1^1320), human fetal
skeletal PEVK (GenBank, AF321609, residues 1^786), human cardiac
titin PEVK (SwissProt, Q10466, residues 1^186) and human soleus
PEVK (GenBank, CAD12456, residues 1^2154) were included in
this search.
2.2. Expression and puri¢cation of the nebulin SH3 domain
The soluble nSH3 (accession number AAB02622) was expressed
using Bl21(DE3)pLysS host cells transfected with a pET3d plasmid
(Novagen, Madison, WI, USA) in LB medium and puri¢ed as de-
scribed previously [7].
The 15N-labeled nSH3 was prepared by growing the bacteria in M9
minimal medium with 15NH4Cl as a sole nitrogen source during the
expression. The incorporation of 15N labels was con¢rmed by matrix-
assisted laser desorption ionization time of £ight (MALDI-TOF) mass
spectroscopy (as a mass increase of 73.6) and heteronuclear NMR
spectroscopy. The folding of the nSH3 was monitored by CD and
thermal titration from 2 to 80‡C. It is completely unfolded at 60‡C,
consistent with the reported value [14].
2.3. Peptide synthesis and puri¢cation
A 28 residue titin PEVK (accession number AF321609) module
(PEPPKEVVPEKKAPVAPPKKPEVPPVKV) (PR), including three
fragments: PR1 (KVPEPPKEVVPE), PR2 (VPEKKAPVAPPK)
and PR3 (KPEVPPVKV), was synthesized and puri¢ed as described
elsewhere [19]. Three 12-mer myopalladin (accession number
AF328296) peptides, MyoP1 (638KTPEPSSPVKEP649), MyoP2
(646VKEPPPVLAKPK657) and MyoP3 (570VEQPPKPKIEGV581),
were synthesized by Sigma Genosys. Human SH3 binding sequence
of guanine nucleotide exchange factor (hSos) SH3 binding domain
(1149VPPPVPPRRR1158) was purchased from Calbiochem. The purity
of the peptides (s 98%) was con¢rmed by analytical high perfor-
mance liquid chromatography and MALDI-TOF.
2.4. Fluorescence spectroscopy
Fluorescence measurements were carried out with an Aminco-Bow-
man Series 2 spectro£uorometer at 2, 10 and 22‡C. The excitation
wavelength was 280 nm (4 nm slit), and the emission wavelength
was 350 nm. In a peptide titration assay, aliquots of peptide solutions
in water (Sos: 0.85 mM, PR: 7.1 mM, PR1: 6.9 mM, PR2: 2.5 mM,
PR3: 11 mM, MyoP1: 6.8 mM, MyoP2: 2.5 mM and MyoP3: 6.7
mM) were added to 2.5 ml of SH3 solution (5 WM) in 10 mM KPi, pH
6.7, and the mixture was stirred in a cuvette for 2^5 min prior to use.
To measure the dissociation constant (Kd), peptide aliquots were
added until no signi¢cant SH3 dependent changes in £uorescence
intensity and maximum wavelength were observed. Binding constants
were calculated from the isotherms assuming a 1:1 stoichiometry with
Sim¢t (version 5.40, University of Manchester, UK).
2.5. CD spectroscopy
All spectra were obtained with a Jasco spectropolarimeter, model
J-715, installed with a standard data analysis program and a Peltier
type temperature control system (Jasco, Tokyo, Japan). The far-UV
spectra were recorded in the range of 190^250 nm with a 0.1 cm path
length cuvette in 10 mM KPi bu¡er at pH 6.7.
2.6. NMR spectroscopy
NMR samples were prepared by dialyzing proteins against 50 mM
NaCl, 10 mM NaPi, pH 7.0. The ¢nal protein concentration was
V0.4 mM in H2O/D2O (9/1). All experiments were acquired with
Varian Unity-Plus 600 MHz spectrometer using a triple resonance
probe at 25‡C. Changes in 15N and 1H chemical shift were monitored
by two-dimensional heteronuclear single quantum coherence (2D-
HSQC) experiments. The titration was stopped when there were no
further chemical shift changes upon addition of the peptide. All NMR
data were processed with Felix (MSI). A tentative assignment was
done by comparing the recently published data on a 60 residue human
adult nebulin SH3 [20]. Our 58 residue human fetal nSH3 is of iden-
tical sequence, but two residues shorter at the N-terminus.
3. Results
3.1. Multiple SH3 binding motifs in titin PEVK isoforms
Our initial survey of six types of SH3 binding motifs (PxxP
[2], class I KxxPxxP [3], class II xPxxPxK [3], xPxxxxPV(A)xP
[2], PxxxKxxKP [17], and PxxDY [18]) in titin and PEVK
sequences from several species revealed an unexpectedly large
number of these motifs that are signi¢cantly enriched in
PEVK segments. Table 1 presents the total number of hits
per sequence. The core PxxP motif is abundant in titin, with
69, 113, and 7 copies in the PEVK segments of human fetal
skeletal, human soleus and cardiac titins. Since the core motif
as such is undoubtedly too short to be useful in identifying
SH3 binding sites, we have focused our analysis on the search
for class I and II motifs, two well established SH3 binding
motifs of seven residues each. There are 11, 17, and one copies
of the class I motif and 14, 30, and 1 copies of the class II
motif in the PEVK segments of human fetal skeletal, human
soleus and cardiac titins, respectively.
The distributions of class I and II motifs along the length of
the titin sequences are plotted in Fig. 1, illustrating the strik-
ing enrichment of these motifs in the PEVK segments of titin
isoforms. In general, it is noted that these motifs are evenly
distributed along the A-band region of the titin. In contrast,
the motifs in the I-band are nearly exclusively found in the
PEVK region, with the remainder of the I-band and the
Z-lines (titin N-terminus) almost free of such motifs. This
segmentation of multiple SH3 binding motifs along the sarco-
mere is striking, and suggests the potential roles for signaling
events in this region.
Table 1
SH3 binding motifs in titin/PEVK isoforms
SH3 binding motif Human fetal skeletal titin (hits) Human soleus titin (hits) Human cardiac titin (hits)
PEVK (786) Titin (N/A) PEVK (2154) Titin (34 350) PEVK (186) Titin (26 926)
PxxP 69 ^ 113 417 7 310
Class Ia
KxxPxxP 11 ^ 17 27 1 12
Class IIa
xPxxPxK 14 ^ 30 62 1 35
xPxxxxPV(A)xP 5 ^ 8 9 0 1
PxxxKxxKP 0 ^ 0 2 0 1
PxxDY 0 ^ 1 5 0 3
aSome sequences can be classi¢ed as both class I and II motifs.
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3.2. Interaction between nebulin SH3 and PEVK peptides
The potential interaction of these SH3 binding motifs is
being evaluated systematically with synthetic peptides and bi-
ophysical methods. Since the intrinsic £uorescence of trypto-
phan and other aromatic residues at the ligand binding site
provides a sensitive binding assay, we ¢rst tested the binding
by adding saturating concentrations of PR, PR1, PR2, and
PR3 to the nSH3 solutions. We also studied in parallel the
proline-rich VPPPVPPRRR decapeptide derived from Sos as
a control peptide because of its high a⁄nity for the N-termi-
nal SH3 domain of Grb2 [21]. In the presence of Sos, PR and
PR2 peptides, there is an increase in the Trp £uorescence
intensity and a blue shift of its maximum at 339 nm for free
nSH3, to 331 nm (nSH3-Sos), 333 nm (nSH3-PR) and 335 nm
(nSH3-PR2) (Fig. 2A). These data suggest that the active site
Trp is moved to an increasingly non-polar environment upon
binding of peptides [22]. This conformational change of nSH3
increases in the order PR2, PR and Sos, as revealed by the
relative increase of £uorescence intensity and the magnitude
of blue shift. Titration of nSH3 with peptides yielded dissoci-
ation constants of 2.3 WM for Sos, 29 WM for PR and 77 WM
for PR2 for a 1:1 stoichiometry at 22‡C (Fig. 2B,C). In con-
trast, the addition of PR1 and PR3 to nSH3 caused the £uo-
rescence intensity to decrease slightly without a¡ecting its
maximum (data not shown), suggesting little contact between
PR1, PR3 and the aromatic cleft of the nSH3 domain.
Interestingly, the £uorescence intensity of the nSH3 at 2‡C
is approximately two-fold higher than at 22‡C (Fig. 2B,C),
indicating more exposure of the Trp residue at higher temper-
ature. Titration of nSH3 with Sos, PR and PR2 at both tem-
peratures demonstrated lower dissociation constants and
tighter binding for these peptides at 2‡C than at 22‡C. The
increased binding a⁄nity at 2‡C may be contributed by both
the conformational changes of nSH3 and a stabilization of the
polyproline type II left-handed (PPII) helices in PEVK pep-
tides at this lower temperature (Ma and Wang, unpublished
observation).
The far-UV CD spectra were then measured to assess if the
binding induces conformational changes in the polypeptide
bonds. The CD of the nSH3^Sos mixture showed a noticeable
intensity increase and a slight blue shift of the negative band
from 201 to 199 nm, as compared to the sum of individual
spectra (Fig. 3A). This may arise from a net increase in either
PPII structure (Ma and Wang, unpublished observation) or
alternatively, the unordered structure [23]. The spectra for
nSH3^PR2 displayed a small, but easily measured increase
near 222 nm, without major changes in the negative band
near 200 nm (Fig. 3B). The increase around 222 nm may
result from the environmental change of the aromatic residues
present in nSH3, in analogy with the spectral changes upon
binding of Fyn^SH3 to 3BP1 and 3BP2 peptides [23]. Titra-
tion of nSH3 with PR2 yielded a dissociation constant of 24
WM for nSH3^PR2 complex at 2‡C (Fig. 3C), consistent with
the Kd of 31 WM derived from £uorescence titration (Fig. 2C).
The nSH3^PR/PR2 interactions are also slightly sensitive to
ionic strength, with dissociation constants reduced about two-
fold at 150 mM KCl, 10 mM KPi at 22‡C (data not shown).
3.3. nSH3 and myopalladin peptides interaction
Bang et al. [15] reported based on yeast two-hybrid assays
that myopalladin binds to nebulin SH3 at the Z-line via
646VKEPPPVLAKPK657 (designated as MyoP2 here), one of
the three proline-rich motifs near the middle of the 145 kDa
protein. The other two SH3 motifs, 638KTPEPSSPVKEP649
Fig. 1. Sarcomere proteins and distribution of class I and class II
SH3 binding motifs along the sequence of titin isoforms. A sche-
matic diagram of a half sarcomere showing the Z-line attachment of
actin (dark green), nebulin (red), myopalladin (green), K-actinin
(pink), and titin (blue). The C-terminal SH3 domain of nebulin is
shown as a solid red circle and the titin PEVK as a yellow string.
Tropomodulin (purple) and myosin (gray and blue) are also shown.
The distribution of class I and class II SH3 binding motifs is shown
as vertical bars along three titin isoforms: human fetal titin (partial,
AF321609), human soleus titin (CAD12456) and human cardiac ti-
tin (I38344). Titin PEVK and A-band segments are shaded in yellow
and cyan, respectively.
Fig. 2. Fluorescence titration of the interaction of nebulin SH3 with
Sos, PEVK and myopalladin peptides. A: Fluorescence spectra of
nSH3 and nSH3^peptide complexes. nSH3 (0.9 WM) and peptides
(Sos: 6.5 WM, PR: 19 WM, PR1: 39 WM, PR2: 43 WM and PR3: 63
WM) were in 10 mM KPi, pH 6.7 at 10‡C. B^D: Binding isotherms
of nSH3-Sos (B), nSH3-PR and nSH3-PR2 (C), and nSH3-MyoP2
(D). nSH3 (5 WM in 10 mM KPi, pH 6.7) was titrated with each
peptide at 2‡C (closed symbols) and 22‡C (open symbols). The £uo-
rescence intensity at 331 nm (Sos and MyoP2), 333 nm (PR) and
335 nm (PR2) was plotted as a function of total ligand concentra-
tions.
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(as MyoP1) and 570VEQPPKPKIEGV581 (as MyoP3), were
excluded by deletion and competition binding assays. We
evaluated the SH3 binding a⁄nity of these motifs by direct
binding assays. Fluorescence titration of nSH3 with MyoP1,
MyoP2 and MyoP3 indicated that all three peptides bind to
nSH3, with two distinct sets of a⁄nities and conformations.
The emission maximum of MyoP2/nSH3 shifted from 339 nm
to 331 nm and MyoP1 and MyoP3 caused the maxima to blue
shift from 339 nm to 335 nm (MyoP1) and 333 nm (MyoP3).
The binding isotherms for MyoP2 were ¢t well with a single
site binding model, yielding Kds of 3.4 WM and 6.2 WM for
2‡C and 22‡C, respectively (Fig. 2D). In contrast, the iso-
therms for MyoP1 and MyoP3 showed no saturation up to
300 WM and displayed a slight sigmoidal shape, indicating a
very di¡erent mode of interaction and much weaker binding.
It is signi¢cant that this micromolar a⁄nity between nSH3
and the MyoP2 peptide is also manifested in vivo [15]. On the
other hand, the class II or PxxP containing peptides (MyoP1
and MyoP3) interact very weakly with nSH3 and no binding
was detectable in vivo [15]. It is noteworthy that, contrary to
an enhancement upon binding of Sos and PR2 to nSH3, the
addition of MyoP2 was accompanied by a progressive
quenching of Trp £uorescence at 350 nm. This may have
resulted from a more e⁄cient energy transfer between Trp
and one or more Tyr residues in the binding site. A similar
quenching of SH3 £uorescence upon ligand binding was re-
ported for Y7V-Grb2-N-SH3 [24].
In contrast to such distinct changes of the Trp environment,
the far-UV CD spectra of nSH3-Sos (Fig. 3A) and nSH3-
MyoP2 (Fig. 3D) are very similar, suggesting the same net
changes in polypeptide backbone conformations upon ligand
binding.
3.4. Interfaces of nSH3^Sos and nSH3^PR2 complexes
Since the change in chemical shifts of protein resonances
upon ligand binding is a sensitive method for de¢ning the
protein interface [25], we also measured the interaction of
nSH3 with Sos and PEVK peptides using HSQC techniques.
As shown in the HSQC spectra of 15N isotope enriched nSH3
(Fig. 4), the number of NMR signals is consistent with the
number of labeled backbone and side chain nitrogen atoms of
nSH3. However, some lower intensity crosspeaks are observed
indicating that additional conformations exist in minor
amounts. Titration of nSH3 with Sos caused increasing chem-
ical shift changes of Trp36 (with indolic NH at 9.95 ppm),
Glu35, Ala15, Asp16, Glu34, Met11 and Tyr54 (arrows in
Fig. 4A), all of which are known to be involved in the li-
gand^SH3 interface [24]. Minor changes were also observed
Fig. 3. CD titration for nSH3 with Sos, PR2 and MyoP2. nSH3 (21 WM in 10 mM KPi at pH 6.7) was titrated with peptides at 22‡C (A) and
2‡C (B^D). The spectra of the mixtures are labeled with ‘nSH3^Sos’, ‘nSH3^PR2’, ‘nSH3^MyoP2’ and the sums of individual spectra of nSH3
and free peptides are labeled as ‘nSH3+Sos’, ‘nSH3+PR2’, ‘nSH3+MyoP2’, respectively. Di¡erence CD spectra of PR2 titration with increasing
PR2/nSH3 molar ratios are shown in (C). The binding isotherm of nSH3-PR2 is plotted based on the di¡erence ellipticity at 222 nm as a func-
tion of total peptide concentration (B, inset).
Fig. 4. 2D 1H^15N HSQC titration of nSH3 with Sos and PR2. The
HSQC spectra were recorded on a 0.37 mM solution of uniformly
15N-labeled nSH3 in 50 mM NaCl, 10 mM NaPi, pH 7.0 (90%
H2O/10% D2O) at 25‡C and then titrated with 9 increments of Sos
up to 0.34 mM or 11 increments of PR2 up to 1.36 mM. The major
chemical shift changes for a¡ected residues are plotted as a series of
circles on each arrow.
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for other residues (Fig. 4A). These residues are located either
adjacent (Asn53, Asp33, Tyr10, Glu17, Ala13, Met7 and
Met37) or outside (Gly39, Gly48, Val18, Leu50, Val29,
Ile26, Ala6, Gln30 and Arg5) of the pocket, suggesting a li-
gand induced conformational change of nSH3. Overall, our
data are consistent with the NMR study of Grb2/SH3^Sos
complex [24].
Titration of nSH3 with PR2 and PR perturbed the chemical
shift of a same set of residues: Asn53, Leu50, Met49, Trp36,
Glu34, Ala15, Tyr38 and Tyr54 (Fig. 4B). These residues are
located in or close to the conserved hydrophobic pocket of the
nSH3 [14]. Further comparison of the HSQC perturbation
spectra of nSH3^PR/PR2 with those of nSH3^Sos showed
highly similar but non-identical chemical shift changes (Fig.
4). The distinct changes of chemical shifts for Asn53, Leu50,
Met49 and Tyr38 in nSH3^PR/PR2 as compared to changes
in Glu35, Asp36 and Met11 in nSH3^Sos probably re£ect the
unique e¡ect of the PPP motif in Sos on the conformation
near the nSH3 binding cleft.
4. Discussion
Our search for six common SH3 binding motifs in titin
isoforms revealed a large number of SH3 motifs, with class
I and II motifs being the most abundant. The distribution of
class I and II motifs along the sequences of titin revealed a
signi¢cant enrichment of these motifs in the PEVK segments
of titin isoforms. It is noted that these motifs are fairly evenly
distributed along the A-band region of titin. In contrast, the
motifs in the I-band are almost exclusively found in the PEVK
region, with the remainder of the I-band and the Z-line (titin
N-terminal) regions free of such motifs. This segmentation of
multiple SH3 binding motifs along the sarcomere is striking,
and suggests a potential signaling role of SH3 proteins in
A-band and I-band assembly, turnover and contractile activ-
ities.
That these PEVK motifs indeed bind to SH3 is supported
by our demonstration of nebulin SH3 binding to PR/PR2
peptides of a highly repetitive motif from human fetal
PEVK (exon 172 of the human titin gene [13]). The PR2 in
the center of the 28 residue PEVK module contains a SH3
binding motif sequence (KxxPxxPxK) with APVAP forming a
polyproline II left-handed helix in solution [19]. Our confor-
mational studies indicate that PR2 binds to the hydrophobic
pocket of nSH3 in a manner that is shared among SH3 and
polyproline peptides [1]. PR1 and PR3, representing the £ank-
ing regions of PR2, do not by themselves bind to nSH3,
despite the presence of a short PPII helix in each peptide
[19]. These £anking regions, however, enhance the overall
a⁄nity of PR towards nSH3 at least two-fold (from 77 WM
of PR2 to 29 WM of PR at 22‡C) (Fig. 2C), suggesting the
possibility of stabilization of PPII in PR2 by £anking regions
of this module or additional interaction outside the hydro-
phobic pocket of nSH3. Given the high sequence homology
of PEVK exons [13], it is reasonable to assume that each of
the SH3 binding motifs in most PEVK exons also binds SH3.
Thus the PEVK segments of skeletal muscle titins, produced
by di¡erential splicing to incorporate selected PEVK exons,
are likely to contain tandem repeats of SH3 binding sites
along their length. Such a multivalent lattice-like receptor is
likely to bind SH3 containing proteins with an avidity that is
signi¢cantly higher than the a⁄nity of each individual site.
The biological signi¢cance of the PEVK/SH3 interaction
remains to be established. Many important SH3 mediated
biological interactions arise from ligand interactions with mi-
cromolar a⁄nity that manifests in a milieu of high local pro-
tein concentrations [1]. Taking into consideration the fact that
the protein concentration of major sarcomere proteins is in
the mM range [26], it is reasonable to expect that both titin
PEVK and nebulin SH3 domain may participate in signaling
pathways by interacting with other SH3 receptors and multi-
ple polyproline ligands at various stages of muscle develop-
ment.
Our previous myo¢bril assembly studies indicated that even
though nebulin was expressed early in developing skeletal
muscle culture, it started to participate in myo¢brillar assem-
bly only at a late stage during the maturation of preformed
IZI complexes when the thin ¢laments became uniform in
length and aligned across the sharp Z-lines [27]. We proposed
that nebulin acts as a molecular ruler in restricting the length
of preformed actin ¢laments by stabilizing the actin ¢laments
at uniform length [27]. How this giant protein is recruited to
the immature sarcomere and how it orients its C-terminal SH3
toward the Z-lines are still unclear. The maturation process
may commence when nebulin is attached to actin ¢laments
and becomes oriented with the same polarity and then at-
tached at its C-terminus to the Z-lines [28]. Our current ¢nd-
Fig. 5. A hypothetical model of nebulin targeting pathway during
IZI assembly. In this model, both the binding of nebulin modules
to actin thin ¢laments (IZI recruitment) and the concurrent or se-
quential binding of nebulin C-terminal SH3 to the multiple binding
sites in the PEVK segment (PEVK targeting) serve to recruit and
orient a large number of nebulin molecules to the IZI complexes
[7]. The Z-line maturation process may commence when nebulin re-
locates to the Z-lines by binding or sliding its SH3 toward myopal-
ladin, K-actinin and actin in the Z-line (Z-line targeting). Finally,
the maturation of the Z-line to form a sharp and regularly aligned
lattice and the attachment of tropomodulin to the pointed end of
the actin and nebulin ¢laments, in turn, transform the actin/tropo-
nin/tropomyosin/nebulin containing composite thin ¢laments into
the mature IZI complexes with uniform length and precise lateral
registration. Irregular and di¡use Z-bands are transformed into
sharp and narrow Z-lines as a result of the maturation process. Col-
or scheme as in Fig. 1.
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ing that nSH3 is capable of binding both to multiple sites
along the length of PEVK segments and to myopalladin sug-
gests that titin PEVK may serve to coordinate and expedite
this orientation and maturation process (see Fig. 5). If this is
true, then titin PEVK represents a new signaling segment that
is distinct from the titin domains that are implicated in the
regulation of ion channels, protein turnover and gene expres-
sion (reviewed in [29]).
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